Literature DB >> 808637

Potentiation of the tumor-specific immune response by Corynebacterium parvum.

M T Scott.   

Abstract

Strong, specific, cell-mediated antitumor immunity resulted from the sc injection into mice of Corynebacterium parvum (CP) mixed with irradiated cells from mastocytoma P815 (MA), whereas injection of irradiated MA alone was without effect. Maximum immunity was achieved with small doses of CP, and the injection sites of CP and irradiated MA did not need to be coincident but required common lymphoid drainage for immunity to result. The process was largely T-cell dependent but not dependent on the development of a specific immune response to CP; it was also demonstrable and effective in a therapy situation. No such immunity was evident after systemic administration of CP and irradiated MA. Simultaneous systemic injection of CP and irradiated MA did, however, nonspecifically reduce the enhancing effect of systemic injection of irradiated MA alone.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 808637     DOI: 10.1093/jnci/55.1.65

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  10 in total

1.  Local microwave hyperthermia (43 degrees C) and stimulation of the macrophage and T-lymphocyte systems in treatment of Guerin epithelioma in rats.

Authors:  M Janiak; W Hryniewicz; J Jeljaszewicz; G Pulverer
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-01-26

2.  Effect of intracerebrally injected Corynebacterium parvum on implanted brain tumor in mice.

Authors:  J D Kennedy; F K Conley
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

3.  Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.

Authors:  E S Dye; R J North; C D Mills
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

4.  Inhibition of Lewis lung carcinoma in mice by local microwave hyperthermia combined with immunomodulating Propionibacterium granulosum KP-45.

Authors:  S Szmigielski; S Zaboklicki; J Gil; J Jeljaszewicz; G Pulverer
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

5.  The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.

Authors:  R Bomford
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

6.  The effect of treatment with Corynebacterium parvum on the development and growth of experimental hematogenic metastases of schwannoma in the rat.

Authors:  J A Bash; T I Mandybur; W A Ritschel
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

7.  Suppression and potentiation of expression of delayed-type hypersensitivity by dextran sulphate.

Authors:  J L'Age-Stehr; T Diamanstein
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

8.  Mechanism of the anti-tumour effect of glucans and fructosans: a comparison with C. parvum.

Authors:  R Bomford; C Moreno
Journal:  Br J Cancer       Date:  1977-07       Impact factor: 7.640

9.  Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells.

Authors:  R Bomford
Journal:  Br J Cancer       Date:  1975-11       Impact factor: 7.640

10.  Corynebacterium parvum enhances colonic cancer in dimethylhydrazine-treated rats.

Authors:  J P Cruse; M R Lewin; C G Clark
Journal:  Br J Cancer       Date:  1978-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.